Publikationen

Multiple immunolabeling with antibodies from the same host species in combination with tyramide signal amplification.

Buchwalow I, Samoilova V, Boecker W, Tiemann M.
Acta Histochem. 2018 May 5. pii: S0065-1281(18)30039-4. doi: 10.1016/j.acthis.2018.05.002.
PMID: 29739626

Tryptase as a polyfunctional component of mast cells.

Atiakshin D, Buchwalow I, Samoilova V, Tiemann M.
Histochem Cell Biol. 2018 Mar 12. doi: 10.1007/s00418-018-1659-8.
PMID: 29532158

Identification of autofluorescent cells in human angioimmunoblastic T-cell lymphoma.

Buchwalow I, Atiakshin D, Samoilova V, Boecker W, Tiemann M.
Histochem Cell Biol. 2018 Feb;149(2):169-177. doi: 10.1007/s00418-017-1624-y. Epub 2017 Dec 2.
PMID: 29197996

Interlaboratory concordance of PD-L1 immunohistochemistry for non-small-cell lung cancer.

Scheel AH, Baenfer G, Baretton G, Dietel M, Diezko R, Henkel T, Heukamp LC, Jasani B, Jöhrens K, Kirchner T, Lasitschka F, Petersen I, Reu S, Schildhaus HU, Schirmacher P, Schwamborn K, Sommer U, Stoss O, Tiemann M, Warth A, Weichert W, Wolf J, Büttner R, Rüschoff J.
Histopathology. 2018 Feb;72(3):449-459. doi: 10.1111/his.13375. Epub 2017 Nov 21.
PMID: 28851100

EGFR immunohistochemistry as biomarker for antibody-based therapy of squamous NSCLC – Experience from the first ring trial of the German Quality Assurance Initiative for Pathology (QuIP®).

Petersen I, Dietel M, Geilenkeuser WJ, Mireskandari M, Weichert W, Steiger K, Scheel AH, Büttner R, Schirmacher P, Warth A, Lasitschka F, Schildhaus HU, Kirchner T, Reu S, Kreipe H, Länger F, Tiemann M, Schulte C, Jöhrens K.
Pathol Res Pract. 2017 Dec;213(12):1530-1535. doi: 10.1016/j.prp.2017.09.021. Epub 2017 Sep 28.
PMID: 29108919

» Artikel lesen

Concordance between Comprehensive Cancer Genome Profiling in Plasma and Tumor Specimens.

Müller JN, Falk M, Talwar J, Neemann N, Mariotti E, Bertrand M, Zacherle T, Lakis S, Menon R, Gloeckner C, Tiemann M, Heukamp LC, Thomas RK, Griesinger F, Heuckmann JM.
J Thorac Oncol. 2017 Oct;12(10):1503-1511. doi: 10.1016/j.jtho.2017.07.014. Epub 2017 Jul 24.
PMID: 28751246

Concordance between comprehensive cancer genome profiling in plasma and tumor specimens.

Müller JN, Falk M, Talwar J, Neemann N, Mariotti E, Bertrand M, Zacherle T, Lakis S, Menon R, Gloeckner C, Tiemann M, Heukamp LC, Thomas RK, Griesinger F, Heuckmann JM.
J Thorac Oncol. 2017 Jul 24. pii: S1556-0864(17)30611-1. doi: 10.1016/j.jtho.2017.07.014. [Epub ahead of print]
PMID: 28751246

Poster

Die MYD88 L265P-Mutation: Ein Werkzeug für die Differentialdiagnose von indolenten Lymphomen mit überlappenden klinisch-pathologischen Eigenschaften? Michael Preukschas Marina Lebherz, Cora Hallas, Markus Tiemann. Jahrestagung der Deutschen Gesellschaft für Hämatologie und Onkologie, 10.-14. Oktober 2014 Hamburg, Germany

Tumor-infiltrierende Lymphozyten in kolorektalen Adenokarzinomen:  Die Entwicklung der Immunantwort in den verschiedenen Tumorstadien. Merle Stamm, Cora Hallas, Markus Falk, Markus Tiemann. Jahrestagung der Deutschen Gesellschaft für Hämatologie und Onkologie, 10.-14. Oktober 2014 Hamburg, Germany

Distribution of driver mutations in a northern German cohort of melanoma patients and limitations of different methods for BRAF testing. Markus Falk, Tobias Berg, Hans-Joachim Schulze, Michael Fluck, Markus Tiemann 8th World Congress of Melanoma, July 17–20 2013, Hamburg, Germany

Incidence of molecular targets (EGFR-mutation, EML4-Alk, BRAF and KRAS) in metastatic NSCLC in a certified lung cancer hospital. Volker Halbfass, Markus Falk, Regina Prenzel, Hans-Georg Dercken, Douglas Scriba, Markus Tiemann, Frank Griesinger 14th Conference of Lung Cancer, 3-7 July 2011, Amsterdam, Netherlands

Various Mutations In JAK2 Exon 12 Induce Divergent Bone Marrow Alterations Hallas C, Schulte C, Heidorn K, Tiemann M 53 ASH Annual Meeting and Exposition 2011, Abstract 4096

to top icon